A. Peter Morello

A. Peter Morello has extensive experience in the pharmaceutical and medical communications industry. A. Peter currently holds the position of Vice President, Medical Communications and Publication Planning at Protagonist Therapeutics, starting in July 2023. Prior to this, they served as the Vice President of Medical Affairs at Rain Oncology for a short period in 2023.

Their longest tenure was at Clovis Oncology, where they held various roles from 2015 to 2023. These roles included Senior Vice President, Medical Affairs, Vice President Medical Affairs, Vice President, Global Publication Planning and Scientific Engagement, Senior Director, Scientific Strategy and Communication, Director, Scientific Strategy and Communication, and Director, Global Medical Information.

Before Clovis Oncology, Morello worked at Onyx Pharmaceuticals as a Director of Global Publication Planning and Associate Director of Publications Planning. A. Peter started their career at Envision Pharma Group in the Scientific Solutions department and then moved on to Nuvilex, Inc. where they served as the Vice President of Research and Development and Director of Research.

Earlier in their career, Morello had roles at Freedom2 Inc. and Freedom 2 Inc., where they worked as a Director of Research and Senior Principal Scientist, respectively. In addition, they founded and served as the principal investigator for College Hill Associates LLC, a client services firm involved in basic research, medical writing, and the preparation of grants for universities and independent contractors.

A. Peter Morello has a Sc.B. degree in Biophysics from Brown University. Additionally, they hold a Ph.D. in Biology from the same institution. The specific years of study or completion for both degrees are not provided.